ArticleCureus2025
A Rare Case of Autoimmune Enteropathy Associated With Lambert-Eaton Myasthenic Syndrome and a Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune enteropathy is a rare intestinal disease characterized by chronic diarrhea and severe malabsorption in the presence of circulating autoantibodies against enterocytes and goblet cells, typically affecting children or young adults. Lambert-Eaton myasthenic syndrome (LEMS) is also a rare autoimmune neuromuscular junction disorder characterized by muscle weakness due to antibodies against the P/Q-type voltage-gated calcium channels (VGCCs) on the presynaptic nerve terminals. We report a case of concurrent diagnoses of autoimmune enteropathy and LEMS in a 24-year-old female patient with a history of autoimmune thyroiditis and vitiligo. The diagnosis of LEMS was established by the typical electromyographic findings and positive antibodies against P/Q-type VGCCs. After malignancies were excluded, treatment with rituximab in combination with intravenous immunoglobulin led to improvement. Within two months of the LEMS diagnosis, the patient presented with severe muscle weakness, chronic diarrhea, vomiting, and weight loss. After a thorough work-up, the diagnosis of autoimmune enteropathy was made, based on severe villous atrophy with a dense inflammatory infiltrate in duodenal biopsies and the exclusion of other causes of chronic diarrhea and non-celiac enteropathy. The patient was treated successfully with total parenteral nutrition, corticosteroids, and azathioprine. To our knowledge, this is one of the first reports of autoimmune enteropathy associated with LEMS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.